New Zealand markets closed

C4 Therapeutics, Inc. (CCCC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.43-0.11 (-1.68%)
At close: 04:00PM EDT
6.69 +0.26 (+4.04%)
After hours: 07:46PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
126,590
29,754
76,124
181,727
Other short-term investments
127,091
246,399
233,155
189,962
Total cash
253,681
276,153
309,279
371,689
Net receivables
11,799
1,473
5,716
4,484
Other current assets
5,709
9,931
10,694
4,836
Total current assets
271,189
287,557
325,689
381,009
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
78,851
85,639
41,969
22,184
Accumulated depreciation
-7,763
-8,123
-6,916
-5,632
Net property, plant and equipment
71,088
77,516
35,053
16,552
Equity and other investments
28,008
60,962
142,200
0
Other long-term assets
6,166
4,805
3,823
2,577
Total non-current assets
105,262
143,283
181,076
19,129
Total assets
376,451
430,840
506,765
400,138
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
2,287
-
-
Accounts payable
1,446
1,172
4,506
5,683
Accrued liabilities
11,243
9,824
8,109
5,331
Deferred revenues
15,471
16,618
31,800
27,603
Other current liabilities
2,043
3,114
413
469
Total current liabilities
42,766
44,546
51,246
43,852
Non-current liabilities
Long-term debt
-
9,195
10,768
10,052
Deferred revenues
21,814
16,895
24,368
53,617
Total non-current liabilities
87,571
97,060
65,913
75,495
Total liabilities
130,337
141,606
117,159
119,347
Stockholders' equity
Common stock
6
5
5
4
Retained earnings
-528,383
-395,890
-267,715
-183,823
Accumulated other comprehensive income
-127
-4,137
-775
13
Total stockholders' equity
246,114
289,234
389,606
280,791
Total liabilities and stockholders' equity
376,451
430,840
506,765
400,138